Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:13:30 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



T:APS - APTOSE BIOSCIENCES INC. - http://aptose.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
APS - T  0.51.66·1.720.81.67+0.053.148.6672531.68  1.77  1.6011.40  1.5914:50:33Mar 2615 min RT 2¢
TSX - T0.51.66·1.720.81.67+0.053.132.9461541.68  1.77  1.6011.40  1.5914:50:3315 min
NEO ATS - U 1.68+0.063.71.11111.63  1.77  1.6314:33:0915 min
Alpha - A 1.68+0.063.71.2251.68  1.70  1.6814:50:3315 min
Pure - P 1.67+0.053.10.2021.69  1.69  1.6714:50:3315 min
Chi-X - X 1.69+0.074.31.52121.67  1.75  1.6312:39:5215 min
CX2 - H 1.75+0.138.06.09141.60  1.75  1.6012:01:2915 min
CXD - D 1.72+0.106.21.21161.68  1.76  1.6814:17:3615 min
TriAct - M 1.624.4638    Sep 11-2015 min
CS2 - S 1.70+0.084.90.1011.70  1.70  1.7011:42:0015 min

Recent Trades - Last 10 of 253
Time ETExPriceChangeVolumeBuyerSellerMarkers
14:50:33T1.670.0520079 CIBC1 AnonymousK
14:50:33A1.680.0610079 CIBC1 AnonymousK
14:50:33P1.670.051001 Anonymous79 CIBCK
14:50:33T1.670.0510079 CIBC79 CIBCK
14:50:33T1.700.081007 TD Sec79 CIBCK
14:50:33T1.700.0810079 CIBC79 CIBCK
14:39:06M1.730.1157 TD Sec7 TD SecE
14:34:32T1.700.0810079 CIBC1 AnonymousK
14:34:31T1.700.0810079 CIBC1 AnonymousK
14:33:09A1.680.0620079 CIBC1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-03-26 18:23C:APS2.13SEDAR Annual ReportSEDAR Annual Report
2024-03-26 18:16C:APS2.13SEDAR MD & ASEDAR MD & A
2024-03-26 18:03C:APS2.13SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-26 16:26C:APS2.13News ReleaseAptose Biosciences spends $33.27M on R&D in 2023
2024-03-18 16:43C:APS2.00News ReleaseAptose to release 2023 results, host call March 26
2024-01-31 16:10C:APS2.63News ReleaseAptose closes financings for $13.7-million (U.S.)
2024-01-26 10:25C:APS2.64News ReleaseAptose prices offering at $1.71 (U.S.) per share
2023-12-11 01:17C:APS3.80News ReleaseAptose releases tuspetinib data from phase 1/2 study
2023-11-30 17:13C:APS3.32News ReleaseAptose Biosciences adds executive duties to Payne
2023-11-09 18:39C:APS4.27SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-09 18:30C:APS4.27SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-09 16:09C:APS4.27News ReleaseAptose spends $8.25-million on R&D in Q3
2023-10-30 11:47C:APS3.80News ReleaseAptose talks Aptivate study results, ESH conference
2023-10-26 11:51C:APS3.49News ReleaseAptose to release Q3 2023 results Nov. 9
2023-10-23 12:50C:APS3.20News ReleaseAptose to provide clinical update at ESH conference
2023-09-06 14:09C:APS5.59News ReleaseAptose Biosciences closes $3M investment by Hanmi
2023-08-10 16:49C:APS5.15SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-10 16:33C:APS5.15News ReleaseAptose cash at $23.3-million at June 30
2023-07-27 16:17C:APS5.20News ReleaseAptose to release Q2 results, host call Aug. 10
2023-06-26 17:19C:APS7.00News ReleaseAptose regains Nasdaq compliance after share rollback